Literature DB >> 33551834

A Proposed Concept for Defective Mitophagy Leading to Late Stage Ineffective Erythropoiesis in Pyruvate Kinase Deficiency.

Annelies Johanna van Vuren1, Eduard Johannes van Beers1, Richard van Wijk2.   

Abstract

Pyruvate kinase deficiency (PKD) is a rare congenital hemolytic anemia caused by mutations in the PKLR gene. Here, we review pathophysiological aspects of PKD, focusing on the interplay between pyruvate kinase (PK)-activity and reticulocyte maturation in the light of ferroptosis, an iron-dependent process of regulated cell death, and in particular its key player glutathione peroxidase 4 (GPX4). GPX4 plays an important role in mitophagy, the key step of peripheral reticulocyte maturation and GPX4 deficiency in reticulocytes results in a failure to fully mature. Mitophagy depends on lipid oxidation, which is under physiological conditions controlled by GPX4. Lack of GPX4 leads to uncontrolled auto-oxidation, which will disrupt autophagosome maturation and thereby perturb mitophagy. Based on our review, we propose a model for disturbed red cell maturation in PKD. A relative GPX4 deficiency occurs due to glutathione (GSH) depletion, as cytosolic L-glutamine is preferentially used in the form of α-ketoglutarate as fuel for the tricarboxylic acid (TCA) cycle at the expense of GSH production. The relative GPX4 deficiency will perturb mitophagy and, subsequently, results in failure of reticulocyte maturation, which can be defined as late stage ineffective erythropoiesis. Our hypothesis provides a starting point for future research into new therapeutic possibilities, which have the ability to correct the oxidative imbalance due to lack of GPX4.
Copyright © 2021 van Vuren, van Beers and van Wijk.

Entities:  

Keywords:  GPX4; ferroptosis; mitophagy; pyruvate kinase deficiency; reticulocytes

Year:  2021        PMID: 33551834      PMCID: PMC7854701          DOI: 10.3389/fphys.2020.609103

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  72 in total

Review 1.  The key role of anaplerosis and cataplerosis for citric acid cycle function.

Authors:  Oliver E Owen; Satish C Kalhan; Richard W Hanson
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

Review 2.  The glutamine-alpha-ketoglutarate (AKG) metabolism and its nutritional implications.

Authors:  Dingfu Xiao; Liming Zeng; Kang Yao; Xiangfeng Kong; Guoyao Wu; Yulong Yin
Journal:  Amino Acids       Date:  2016-05-09       Impact factor: 3.520

Review 3.  How we manage patients with pyruvate kinase deficiency.

Authors:  Rachael F Grace; D Mark Layton; Wilma Barcellini
Journal:  Br J Haematol       Date:  2019-01-25       Impact factor: 6.998

4.  Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease.

Authors:  C R Zerez; N A Lachant; S J Lee; K R Tanaka
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

5.  A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.

Authors:  Yutaka Niihara; Scott T Miller; Julie Kanter; Sophie Lanzkron; Wally R Smith; Lewis L Hsu; Victor R Gordeuk; Kusum Viswanathan; Sharada Sarnaik; Ifeyinwa Osunkwo; Edouard Guillaume; Swayam Sadanandan; Lance Sieger; Joseph L Lasky; Eduard H Panosyan; Osbourne A Blake; Tamara N New; Rita Bellevue; Lan T Tran; Rafael L Razon; Charles W Stark; Lynne D Neumayr; Elliott P Vichinsky
Journal:  N Engl J Med       Date:  2018-07-19       Impact factor: 91.245

6.  A short linear motif in BNIP3L (NIX) mediates mitochondrial clearance in reticulocytes.

Authors:  Ji Zhang; Melanie R Loyd; Mindy S Randall; M Brett Waddell; Richard W Kriwacki; Paul A Ney
Journal:  Autophagy       Date:  2012-08-21       Impact factor: 16.016

7.  Fifteen novel mutations in PKLR associated with pyruvate kinase (PK) deficiency: structural implications of amino acid substitutions in PK.

Authors:  Richard van Wijk; Eric G Huizinga; Annet C W van Wesel; Brigitte A van Oirschot; Michael A Hadders; Wouter W van Solinge
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

8.  Erythrocyte populations in pyruvate kinase deficiency anaemia following splenectomy. II. Cell deformability.

Authors:  P F Leblond; L Coulombe; J Lyonnais
Journal:  Br J Haematol       Date:  1978-05       Impact factor: 6.998

9.  N-acetylcysteine reduces oxidative stress in sickle cell patients.

Authors:  Erfan Nur; Dees P Brandjes; Tom Teerlink; Hans-Martin Otten; Ronald P J Oude Elferink; Frits Muskiet; Ludo M Evers; Hugo ten Cate; Bart J Biemond; Ashley J Duits; John-John B Schnog
Journal:  Ann Hematol       Date:  2012-02-10       Impact factor: 3.673

Review 10.  Erythrocyte pyruvate kinase deficiency: 2015 status report.

Authors:  Rachael F Grace; Alberto Zanella; Ellis J Neufeld; D Holmes Morton; Stefan Eber; Hassan Yaish; Bertil Glader
Journal:  Am J Hematol       Date:  2015-08-14       Impact factor: 10.047

View more
  2 in total

1.  Diagnosis and clinical management of enzymopathies.

Authors:  Lucio Luzzatto
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Role of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm.

Authors:  Zhijun Liu; Yifei Le; Hang Chen; Ji Zhu; Dezhao Lu
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.